🔗 Visit the ClinicalTrials.gov page for NCT01649024
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial. | Lancet Oncol | 2013 | 3.28 |
| 2 | CTLA-4 blockade in tumor models: an overview of preclinical and translational research. | Cancer Immun | 2013 | 1.71 |
| 3 | Trial watch: Monoclonal antibodies in cancer therapy. | Oncoimmunology | 2013 | 1.41 |
| 4 | Cancer immunotherapy in clinical practice -- the past, present, and future. | Chin J Cancer | 2014 | 0.98 |
| 5 | Targeting CD8+ T-cell tolerance for cancer immunotherapy. | Immunotherapy | 2014 | 0.81 |
| 6 | Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. | Oncoimmunology | 2015 | 0.77 |